Loading…
Attending this event?

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Clinical Development [clear filter]
Tuesday, September 20
 

1:00pm EDT

Panel: Lessons Learned from the Pandemic: The Future of Patient Recruitment
Speakers
avatar for Jason Josie

Jason Josie

Director, Site Management, Global Clinical Operations, BeiGene
Seasoned clinical research professional with over 24 years of research experience (including pre-clinical and data management) and over 20 years of industry experience (PH I-IV). Diverse background in various field, management and leadership roles. Experience working on both the CRO... Read More →
avatar for LaShell Robinson

LaShell Robinson

Director, Diversity & Inclusion in Clinical Trials, Takeda Pharmaceuticals
LaShell Robinson is the Director of Diversity & Inclusion in Clinical trials at Takeda where she leads the company’s strategic vision for increasing the diversity of Takeda’s clinical research programs by fostering partnerships & implementing strategies focused on education, awareness... Read More →


Tuesday September 20, 2022 1:00pm - 1:45pm EDT

1:45pm EDT

Presentation: Early Phase Chemical Technologies That Accelerate Early Phase Development
Advanced chemical development technologies are often underutilized in early development because their implementation timeframe cannot match the tempo of early phase activities. This deprives the pre-IND to phase II sector of valuable tools that could benefit early chemical development efforts. 2 such tools considered unwieldy early on are mechanistic probing of problematic reactions and enzyme evolution. Asymchem has developed tools and systems to rapidly implement these 2 technologies and allow them to be deployed much earlier and more comprehensively than is typically considered possible. These programs provide mechanistic information to rescue “dead” chemical routes or allow multiple interation enzyme evolution that provides fully evolved enzymes at a speed which keeps pace with other early phase development activities.

Presented by Asymchem

Speakers
avatar for Dr. Jon Brice

Dr. Jon Brice

Vice President of BD, Asymchem
Dr. Jon Brice brings over 25 years of experience to the chemical pharmaceutical development and manufacturing industry. He earned his BS in Chemistry from Reed College followed by his PhD in Organic Chemistry from the University of Illinois Urbana-Champaign. In Dr. Brice’s early... Read More →


Tuesday September 20, 2022 1:45pm - 2:15pm EDT

2:15pm EDT

Panel: Transitioning to Decentralized Clinical Trials
Moderator
avatar for Amir Lahav Sc.D

Amir Lahav Sc.D

Digital Healthcare Innovation, Head of Strategic R&D, Mitsubishi Tanabe Pharma America
Amir is a Digital Health Advisor and a leading innovator at the forefront of tech innovation and clinical research. Amir has nearly two decades of experience in the biotech and healthcare industries. He currently sits on the Advisory Board of leading HealthTech startups (Curbase... Read More →

Speakers
avatar for Antoniu Fantana,  PhD

Antoniu Fantana, PhD

Sr. Director, Lead Emerging Technology Strategy - Clinical Design, Delivery and Analytics, Eli Lilly and Company
Tony Fantana is passionate about creatively solving high unmet medical need problems by assembling, leading, and developing great teams. He currently leads the emerging technology strategy in clinical development at Eli Lilly & Company. There, he is responsible for executing pilots... Read More →
avatar for Joel Morse

Joel Morse

CEO and Co-Founder, Curavit Clinical Research
Joel Morse is CEO and co-founder of Curavit Clinical Research. Founded in late 2019, Curavit is a virtual CRO focused on designing and executing Decentralized Clinical Trials (DCTs). Prior to founding Curavit, Joel was co-founder and CEO of C3i, a global provider of clinical trial... Read More →


Tuesday September 20, 2022 2:15pm - 3:00pm EDT
 
Filter sessions
Apply filters to sessions.